Company: LGN
Filing Date: 2025-04-30
Form Type: DRS/A
Source: 0000950123-25-003868
Chunk: 117

Company: Legence Corp.
Filing Date: 2025-04-30
Form: DRS/A
Chunk 117
---
277,411 |     |   |  17.2 | % |     |   |   342,490 |     |   |  16.3 | % |
| Mixed-use(5)                  |     |                         |    77,659 |     |   |   6.2 | % |     |   |   125,922 |     |   |   7.8 | % |     |   |   159,045 |     |   |   7.6 | % |
| State & local government(6)   |     |                         |    58,264 |     |   |   4.7 | % |     |   |    72,263 |     |   |   4.5 | % |     |   |    93,500 |     |   |   4.5 | % |
| Other(7)                      |     |                         |   232,259 |     |   |  18.6 | % |     |   |   303,466 |     |   |  18.8 | % |     |   |   378,705 |     |   |  18.0 | % |
| Revenue                       |     | $                       | 1,246,501 |     |   | 100.0 | % |     | $ | 1,615,062 |     |   | 100.0 | % |     | $ | 2,098,602 |     |   | 100.0 | % |

| (1) | The information provided in the table under “Revenue by Client End Market” represents the revenue                                                        
 generated from clients in each of the end markets indicated in that period; provided, that where the client is a lessor, we use the lessee’s end market. |

| (2) | Includes facilities housing servers, networking equipment, systems critical for storing and managing data,                                                                                                        
 operational facilities for internet service providers, software companies, IT development hubs, AI development facilities, and high-precision manufacturing plants producing semiconductor chips and electronics. |

| (3) | Includes colleges, universities and research facilities, as well as kindergarten through twelfth grade 
 education facilities.                                                                                  |

| (4) | Includes facilities supporting life sciences research and development, pharmaceutical manufacturing and 
 healthcare facilities providing inpatient and outpatient health services.                               |

| (5) | Includes buildings or complexes combining